R. Longarini

615 total citations
11 papers, 493 citations indexed

About

R. Longarini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R. Longarini has authored 11 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in R. Longarini's work include Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (4 papers). R. Longarini is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (4 papers). R. Longarini collaborates with scholars based in Italy and United States. R. Longarini's co-authors include Gabriele Tancini, Paolo Lissoni, Mario Mandalà, Sandro Barni, Franco Paolorossi, Massimo Vaghi, Antonio Ardizzoia, Fabio Malugani, Antonia Martinetti and L. Ferrari and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R. Longarini

11 papers receiving 472 citations

Peers

R. Longarini

ONCOL

PRM

EAS

HEPAT

Zhiming Huang China

P. Lai Italy

Dabing Huang China

Hyelin Na South Korea

Pascale Plas France

Valérie Domergue France

Etsuro Onuma United States

R. Garcı́a-Cañero Spain

Juergen Wagner Germany

Stefanie Petzold Germany

Zhiming Huang China

R. Longarini

99 ×0.4

ONCOL

26 ×0.2

PRM

53 ×0.4

EAS

140 ×1.4

23 ×0.4

HEPAT

Citations per year, relative to R. Longarini R. Longarini (= 1×) peers Zhiming Huang

Countries citing papers authored by R. Longarini

Since Specialization

Citations

This map shows the geographic impact of R. Longarini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Longarini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Longarini more than expected).

Fields of papers citing papers by R. Longarini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Longarini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Longarini. The network helps show where R. Longarini may publish in the future.

Co-authorship network of co-authors of R. Longarini

This figure shows the co-authorship network connecting the top 25 collaborators of R. Longarini. A scholar is included among the top collaborators of R. Longarini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Longarini. R. Longarini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Morano, Federica, Salvatore Corallo, Maria Di Bartolomeo, et al.. (2018). Negative hyper-selection of RAS wild-type (wt) metastatic colorectal cancer (mCRC) patients randomized to first-line FOLFOX plus panitumumab (Pan) followed by maintenance therapy with either 5FU/LV plus pan or single-agent pan: Translational analyses of the VALENTINO study. Annals of Oncology. 29. viii716–viii716. 2 indexed citations

Cremolini, Chiara, Fotios Loupakis, Sara Lonardi, et al.. (2015). Early tumor shrinkage and depth of response predict long-term outcome in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab: results from phase III TRIBE trial by the Gruppo Oncologico del Nord Ovest. Annals of Oncology. 26(6). 1188–1194. 135 indexed citations

Bartolomeo, Maria Di, Emilio Bajetta, Roberto Buzzoni, et al.. (2006). A dose finding study with erlotinib in combination to irinotecan and capecitabine in metastatic colorectal cancer (mCRC) patients. Journal of Clinical Oncology. 24(18_suppl). 13075–13075. 2 indexed citations

Martinetti, Antonia, Emilio Bajetta, Luca Ferrari, et al.. (2004). Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. Endocrine Related Cancer. 11(4). 771–779. 29 indexed citations

Bajetta, E., Luigi Celio, Roberto Buzzoni, et al.. (2003). Phase II study of pemetrexed disodium (Alimta®) administered with oral folic acid in patients with advanced gastric cancer. Annals of Oncology. 14(10). 1543–1548. 49 indexed citations

Bajetta, Emilio, Antonia Martinetti, Nicoletta Zilembo, et al.. (2002). Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism. Annals of Oncology. 13(7). 1059–1066. 37 indexed citations

Celio, Luigi, Roberto Buzzoni, R. Longarini, Alfonso Marchianò, & Emilio Bajetta. (2002). Pemetrexed in gastric cancer: Clinical experience and future perspectives. Seminars in Oncology. 29(6). 63–68. 9 indexed citations

Celio, Luigi, Emilio Bajetta, Roberto Buzzoni, et al.. (2001). Pemetrexed disodium (Alimta™) with folic acid (FA) in advanced or metastatic gastric cancer. European Journal of Cancer. 37. S312–S312. 2 indexed citations

Procopio, Giuseppe, Emilio Bajetta, Laura Catena, et al.. (2001). Safety and activity of Capecitabine in elderly patients with advanced breast cancer. European Journal of Cancer. 37. S197–S197. 7 indexed citations

10.

Lissoni, Paolo, Sandro Barni, Mario Mandalà, et al.. (1999). Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. European Journal of Cancer. 35(12). 1688–1692. 208 indexed citations

11.

Lissoni, Paolo, Mario Mandalà, F Brivio, et al.. (1998). Physiopathology of IL-12 in human solid neoplasms: blood levels of IL-12 in early or advanced cancer patients, and their variations with surgery and immunotherapy.. PubMed. 12(1-2). 38–41. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact